STOCK TITAN

PetMed Express, Inc. - PETS STOCK NEWS

Welcome to our dedicated page for PetMed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on PetMed Express stock.

PetMed Express, Inc. (NASDAQ: PETS), widely recognized as PetMeds, is America's largest pet pharmacy. Established in 1996, PetMeds provides both prescription and non-prescription pet medications, health products, and nutritional supplements for dogs, cats, and horses directly to consumers at substantial savings. The company operates from a single location, delivering exceptional value and convenience to millions of satisfied customers nationwide.

PetMeds generates revenue primarily by selling pet medications and supplies, targeting retail consumers. The company prides itself on being a trusted pet health expert, offering competitive prices and convenient access to a wide range of products. Pet parents can purchase these products through PetMeds' toll-free number (1-800-PetMeds) or online at www.petmeds.com.

Recently, PetMeds partnered with Hill's Pet Nutrition to offer Hill's Science Diet products on PetMeds' platform starting March 1, 2024. To celebrate this partnership, PetMeds launched a promotional giveaway, providing a year's worth of Hill's Science Diet to one lucky winner. This initiative aligns with PetMeds' commitment to responsible pet ownership and support for animal shelters facing capacity crises.

PetMeds also offers innovative services like Pumpkin® pet insurance plans and same-day VetLive® telehealth appointments, making veterinary care more accessible and affordable. Furthermore, through its wholly-owned subsidiary, PetCareRx, PetMeds extends its reach by providing additional pet health products and services.

The company's financial stability is underscored by its consistent performance and strategic partnerships. PetMeds is scheduled to host a conference call on February 8, 2024, to discuss its third-quarter results, followed by a Q&A session. This event provides an opportunity for investors and stakeholders to gain insights into the company's operations and future plans.

For more information, visit www.petmeds.com or contact PetMeds' investor relations team at investor@petmeds.com.

Rhea-AI Summary
PetMed Express, Inc. announces restatement of financial statements due to accounting errors. Preliminary financial results for Q3 2023 show an 11% increase in net sales. Gross profit expected to be $17.9 million, up from $15.2 million. Cash and equivalents at $49.4 million. Restatement to affect multiple periods, decreasing general and administrative expense for fiscal year 2023 by $6-8 million and increasing net income. No expected impact on fiscal year 2024 revenue, cost of goods sold, or cash.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
-
Rhea-AI Summary
PetMed Express, Inc. (Nasdaq: PETS) will hold a conference call on February 8, 2024, to discuss its financial results for the fiscal third quarter ended December 31, 2023. The call will be hosted by PetMeds’ management and will include a question and answer period. The company's financial results will be issued in a press release prior to the call. The call will be accessible via U.S. and international dial-in numbers, as well as a webcast link. A telephonic replay will also be available after the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
-
Rhea-AI Summary
PetMed Express, Inc. (NASDAQ: PETS) appoints Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning. Ms. Campbell has served on PetMeds' Board since 2018 and will continue to serve as Chair of the Compensation Committee and a member of the Audit and Corporate Governance and Nominating Committees. As Chairman, Ms. Campbell succeeds Dr. Gian Fulgoni, who will remain a member of the Board and its various committees and continue to chair the Board's Corporate Governance and Nominating Committee.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
none
Rhea-AI Summary
PetMed Express, Inc. (PETS) revealed the results of a new survey conducted by OnePoll that show just how much pet parents miss their beloved friends when they are at work. Four in 10 pet parents said they would take a lower salary to work from home in order to be closer to their pets. The PetMeds® survey found that pet parents begin to miss their pets on average just 37 minutes after being apart.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
none
-
Rhea-AI Summary
PetMed Express, Inc. (PetMeds®, NASDAQ: PETS) announces the creation of its Veterinarian Advisory Board led by Dr. Lori Teller, aiming to improve outcomes for pets and pet parents. The board will consist of expert voices in the veterinary space, offering insights into pet care and wellbeing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
management
-
Rhea-AI Summary
PetMed Express, Inc. (NASDAQ: PETS) announced its financial results for Q2 2023. Net sales were $71.0 million, up 9% YoY. New customers increased by 25% YoY. Net loss was $70 thousand compared to net income of $2.6 million in Q2 2022. Adjusted EBITDA was $3.2 million, a decrease of 55% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.95%
Tags
Rhea-AI Summary
PetMed Express, Inc. to hold conference call to discuss financial results for Q2 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.37%
Tags
-
Rhea-AI Summary
PetMeds® now offers pet insurance through Pumpkin Insurance Services, making it easier and more affordable for pet owners to plan for accidents and illnesses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.52%
Tags
none
-
Rhea-AI Summary
PetMed Express, Inc. announces participation in investor conferences in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.87%
Tags
dividends earnings

FAQ

What is the current stock price of PetMed Express (PETS)?

The current stock price of PetMed Express (PETS) is $4.97 as of December 20, 2024.

What is the market cap of PetMed Express (PETS)?

The market cap of PetMed Express (PETS) is approximately 107.0M.

What does PetMed Express, Inc. do?

PetMed Express, Inc., also known as PetMeds, is America's largest pet pharmacy. The company sells prescription and non-prescription pet medications, health products, and nutritional supplements directly to consumers.

Where can I buy PetMeds products?

You can purchase PetMeds products through their toll-free number (1-800-PetMeds) or online at www.petmeds.com.

What recent partnerships has PetMeds announced?

PetMeds recently partnered with Hill's Pet Nutrition to offer Hill's Science Diet products on their platform starting March 1, 2024.

What is the significance of PetMeds’ partnership with Hill's Pet Nutrition?

The partnership allows PetMeds to offer Hill's Science Diet products, aligning with their commitment to responsible pet ownership and supporting animal shelters.

Does PetMeds offer pet insurance?

Yes, PetMeds offers Pumpkin® pet insurance plans, making veterinary care more accessible and affordable.

What other services does PetMeds provide?

In addition to selling pet medications and health products, PetMeds offers same-day VetLive® telehealth appointments.

Who are PetMeds' primary customers?

PetMeds primarily serves retail consumers, providing products and services directly to pet parents across the U.S.

When is PetMeds' next conference call?

PetMeds will host their next conference call on February 8, 2024, at 4:30 PM Eastern Time.

How can I contact PetMeds for investor relations?

For investor relations inquiries, you can contact PetMeds at investor@petmeds.com or call (561) 489-5315.

What is PetCareRx?

PetCareRx is a wholly-owned subsidiary of PetMeds, providing additional pet health products and services via www.petcarerx.com.

PetMed Express, Inc.

Nasdaq:PETS

PETS Rankings

PETS Stock Data

107.04M
18.86M
8.1%
47.84%
6.51%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States of America
DELRAY BEACH